Global Molecular Influenza Diagnostic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Molecular Influenza Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Molecular Influenza Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Molecular Influenza Diagnostic market. Molecular Influenza Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Molecular Influenza Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Molecular Influenza Diagnostic market.
Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Molecular Influenza Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Molecular Influenza Diagnostic market. It may include historical data, market segmentation by Type (e.g., Reverse Transcription Polymerase Chain Reaction (RT-PCR), Nucleic Acid Sequence Based Amplification (NASBA) Tests), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Molecular Influenza Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Molecular Influenza Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Molecular Influenza Diagnostic industry. This include advancements in Molecular Influenza Diagnostic technology, Molecular Influenza Diagnostic new entrants, Molecular Influenza Diagnostic new investment, and other innovations that are shaping the future of Molecular Influenza Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Molecular Influenza Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Molecular Influenza Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Molecular Influenza Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Molecular Influenza Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Molecular Influenza Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Molecular Influenza Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Molecular Influenza Diagnostic market.
Market Segmentation:
Molecular Influenza Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Molecular Influenza Diagnostic market size was valued at US$ million in 2023. With growing demand in downstream market, the Molecular Influenza Diagnostic is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Molecular Influenza Diagnostic market. Molecular Influenza Diagnostic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Molecular Influenza Diagnostic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Molecular Influenza Diagnostic market.
Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Molecular Influenza Diagnostic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Molecular Influenza Diagnostic market. It may include historical data, market segmentation by Type (e.g., Reverse Transcription Polymerase Chain Reaction (RT-PCR), Nucleic Acid Sequence Based Amplification (NASBA) Tests), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Molecular Influenza Diagnostic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Molecular Influenza Diagnostic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Molecular Influenza Diagnostic industry. This include advancements in Molecular Influenza Diagnostic technology, Molecular Influenza Diagnostic new entrants, Molecular Influenza Diagnostic new investment, and other innovations that are shaping the future of Molecular Influenza Diagnostic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Molecular Influenza Diagnostic market. It includes factors influencing customer ' purchasing decisions, preferences for Molecular Influenza Diagnostic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Molecular Influenza Diagnostic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Molecular Influenza Diagnostic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Molecular Influenza Diagnostic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Molecular Influenza Diagnostic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Molecular Influenza Diagnostic market.
Market Segmentation:
Molecular Influenza Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Reverse Transcription Polymerase Chain Reaction (RT-PCR)
- Nucleic Acid Sequence Based Amplification (NASBA) Tests
- Loop-mediated Isothermal Amplification-Based Assays (LAMP)
- Simple Amplification-based Assays (SAMBA)
- Hospitals
- POCT
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Abbott (Include Alere)
- Roche
- SIEMENS
- Analytik Jena
- Quidel
- Thermo Fisher
- Meridian Bioscience
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Influenza Diagnostic Market Size 2019-2030
2.1.2 Molecular Influenza Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular Influenza Diagnostic Segment by Type
2.2.1 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
2.2.2 Nucleic Acid Sequence Based Amplification (NASBA) Tests
2.2.3 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
2.2.4 Simple Amplification-based Assays (SAMBA)
2.3 Molecular Influenza Diagnostic Market Size by Type
2.3.1 Molecular Influenza Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Molecular Influenza Diagnostic Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Molecular Influenza Diagnostic Market Size by Application
2.5.1 Molecular Influenza Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
3 MOLECULAR INFLUENZA DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Molecular Influenza Diagnostic Market Size Market Share by Players
3.1.1 Global Molecular Influenza Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Influenza Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR INFLUENZA DIAGNOSTIC BY REGIONS
4.1 Molecular Influenza Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Molecular Influenza Diagnostic Market Size Growth (2019-2024)
4.3 APAC Molecular Influenza Diagnostic Market Size Growth (2019-2024)
4.4 Europe Molecular Influenza Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular Influenza Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Molecular Influenza Diagnostic Market Size by Country (2019-2024)
5.2 Americas Molecular Influenza Diagnostic Market Size by Type (2019-2024)
5.3 Americas Molecular Influenza Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Influenza Diagnostic Market Size by Region (2019-2024)
6.2 APAC Molecular Influenza Diagnostic Market Size by Type (2019-2024)
6.3 APAC Molecular Influenza Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Influenza Diagnostic by Country (2019-2024)
7.2 Europe Molecular Influenza Diagnostic Market Size by Type (2019-2024)
7.3 Europe Molecular Influenza Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Influenza Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR INFLUENZA DIAGNOSTIC MARKET FORECAST
10.1 Global Molecular Influenza Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Molecular Influenza Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Molecular Influenza Diagnostic Forecast
10.1.3 APAC Molecular Influenza Diagnostic Forecast
10.1.4 Europe Molecular Influenza Diagnostic Forecast
10.1.5 Middle East & Africa Molecular Influenza Diagnostic Forecast
10.2 Americas Molecular Influenza Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Molecular Influenza Diagnostic Market Forecast
10.2.2 Canada Molecular Influenza Diagnostic Market Forecast
10.2.3 Mexico Molecular Influenza Diagnostic Market Forecast
10.2.4 Brazil Molecular Influenza Diagnostic Market Forecast
10.3 APAC Molecular Influenza Diagnostic Forecast by Region (2025-2030)
10.3.1 China Molecular Influenza Diagnostic Market Forecast
10.3.2 Japan Molecular Influenza Diagnostic Market Forecast
10.3.3 Korea Molecular Influenza Diagnostic Market Forecast
10.3.4 Southeast Asia Molecular Influenza Diagnostic Market Forecast
10.3.5 India Molecular Influenza Diagnostic Market Forecast
10.3.6 Australia Molecular Influenza Diagnostic Market Forecast
10.4 Europe Molecular Influenza Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Molecular Influenza Diagnostic Market Forecast
10.4.2 France Molecular Influenza Diagnostic Market Forecast
10.4.3 UK Molecular Influenza Diagnostic Market Forecast
10.4.4 Italy Molecular Influenza Diagnostic Market Forecast
10.4.5 Russia Molecular Influenza Diagnostic Market Forecast
10.5 Middle East & Africa Molecular Influenza Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Molecular Influenza Diagnostic Market Forecast
10.5.2 South Africa Molecular Influenza Diagnostic Market Forecast
10.5.3 Israel Molecular Influenza Diagnostic Market Forecast
10.5.4 Turkey Molecular Influenza Diagnostic Market Forecast
10.5.5 GCC Countries Molecular Influenza Diagnostic Market Forecast
10.6 Global Molecular Influenza Diagnostic Forecast by Type (2025-2030)
10.7 Global Molecular Influenza Diagnostic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Molecular Influenza Diagnostic Product Offered
11.1.3 BD Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Information
11.2.2 Abbott (Include Alere) Molecular Influenza Diagnostic Product Offered
11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott (Include Alere) Main Business Overview
11.2.5 Abbott (Include Alere) Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Molecular Influenza Diagnostic Product Offered
11.3.3 Roche Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Information
11.4.2 SIEMENS Molecular Influenza Diagnostic Product Offered
11.4.3 SIEMENS Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 SIEMENS Main Business Overview
11.4.5 SIEMENS Latest Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Information
11.5.2 Analytik Jena Molecular Influenza Diagnostic Product Offered
11.5.3 Analytik Jena Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Analytik Jena Main Business Overview
11.5.5 Analytik Jena Latest Developments
11.6 Quidel
11.6.1 Quidel Company Information
11.6.2 Quidel Molecular Influenza Diagnostic Product Offered
11.6.3 Quidel Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Quidel Main Business Overview
11.6.5 Quidel Latest Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Information
11.7.2 Thermo Fisher Molecular Influenza Diagnostic Product Offered
11.7.3 Thermo Fisher Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Main Business Overview
11.7.5 Thermo Fisher Latest Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Information
11.8.2 Meridian Bioscience Molecular Influenza Diagnostic Product Offered
11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Meridian Bioscience Main Business Overview
11.8.5 Meridian Bioscience Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Molecular Influenza Diagnostic Product Offered
11.9.3 BioMerieux Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Information
11.10.2 Sekisui Diagnostics Molecular Influenza Diagnostic Product Offered
11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sekisui Diagnostics Main Business Overview
11.10.5 Sekisui Diagnostics Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Molecular Influenza Diagnostic Product Offered
11.11.3 Response Biomedical Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Information
11.12.2 SA Scientific Molecular Influenza Diagnostic Product Offered
11.12.3 SA Scientific Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 SA Scientific Main Business Overview
11.12.5 SA Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Influenza Diagnostic Market Size 2019-2030
2.1.2 Molecular Influenza Diagnostic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular Influenza Diagnostic Segment by Type
2.2.1 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
2.2.2 Nucleic Acid Sequence Based Amplification (NASBA) Tests
2.2.3 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
2.2.4 Simple Amplification-based Assays (SAMBA)
2.3 Molecular Influenza Diagnostic Market Size by Type
2.3.1 Molecular Influenza Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
2.4 Molecular Influenza Diagnostic Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Molecular Influenza Diagnostic Market Size by Application
2.5.1 Molecular Influenza Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
3 MOLECULAR INFLUENZA DIAGNOSTIC MARKET SIZE BY PLAYER
3.1 Molecular Influenza Diagnostic Market Size Market Share by Players
3.1.1 Global Molecular Influenza Diagnostic Revenue by Players (2019-2024)
3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Influenza Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR INFLUENZA DIAGNOSTIC BY REGIONS
4.1 Molecular Influenza Diagnostic Market Size by Regions (2019-2024)
4.2 Americas Molecular Influenza Diagnostic Market Size Growth (2019-2024)
4.3 APAC Molecular Influenza Diagnostic Market Size Growth (2019-2024)
4.4 Europe Molecular Influenza Diagnostic Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular Influenza Diagnostic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Molecular Influenza Diagnostic Market Size by Country (2019-2024)
5.2 Americas Molecular Influenza Diagnostic Market Size by Type (2019-2024)
5.3 Americas Molecular Influenza Diagnostic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Influenza Diagnostic Market Size by Region (2019-2024)
6.2 APAC Molecular Influenza Diagnostic Market Size by Type (2019-2024)
6.3 APAC Molecular Influenza Diagnostic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Influenza Diagnostic by Country (2019-2024)
7.2 Europe Molecular Influenza Diagnostic Market Size by Type (2019-2024)
7.3 Europe Molecular Influenza Diagnostic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Influenza Diagnostic by Region (2019-2024)
8.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR INFLUENZA DIAGNOSTIC MARKET FORECAST
10.1 Global Molecular Influenza Diagnostic Forecast by Regions (2025-2030)
10.1.1 Global Molecular Influenza Diagnostic Forecast by Regions (2025-2030)
10.1.2 Americas Molecular Influenza Diagnostic Forecast
10.1.3 APAC Molecular Influenza Diagnostic Forecast
10.1.4 Europe Molecular Influenza Diagnostic Forecast
10.1.5 Middle East & Africa Molecular Influenza Diagnostic Forecast
10.2 Americas Molecular Influenza Diagnostic Forecast by Country (2025-2030)
10.2.1 United States Molecular Influenza Diagnostic Market Forecast
10.2.2 Canada Molecular Influenza Diagnostic Market Forecast
10.2.3 Mexico Molecular Influenza Diagnostic Market Forecast
10.2.4 Brazil Molecular Influenza Diagnostic Market Forecast
10.3 APAC Molecular Influenza Diagnostic Forecast by Region (2025-2030)
10.3.1 China Molecular Influenza Diagnostic Market Forecast
10.3.2 Japan Molecular Influenza Diagnostic Market Forecast
10.3.3 Korea Molecular Influenza Diagnostic Market Forecast
10.3.4 Southeast Asia Molecular Influenza Diagnostic Market Forecast
10.3.5 India Molecular Influenza Diagnostic Market Forecast
10.3.6 Australia Molecular Influenza Diagnostic Market Forecast
10.4 Europe Molecular Influenza Diagnostic Forecast by Country (2025-2030)
10.4.1 Germany Molecular Influenza Diagnostic Market Forecast
10.4.2 France Molecular Influenza Diagnostic Market Forecast
10.4.3 UK Molecular Influenza Diagnostic Market Forecast
10.4.4 Italy Molecular Influenza Diagnostic Market Forecast
10.4.5 Russia Molecular Influenza Diagnostic Market Forecast
10.5 Middle East & Africa Molecular Influenza Diagnostic Forecast by Region (2025-2030)
10.5.1 Egypt Molecular Influenza Diagnostic Market Forecast
10.5.2 South Africa Molecular Influenza Diagnostic Market Forecast
10.5.3 Israel Molecular Influenza Diagnostic Market Forecast
10.5.4 Turkey Molecular Influenza Diagnostic Market Forecast
10.5.5 GCC Countries Molecular Influenza Diagnostic Market Forecast
10.6 Global Molecular Influenza Diagnostic Forecast by Type (2025-2030)
10.7 Global Molecular Influenza Diagnostic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Molecular Influenza Diagnostic Product Offered
11.1.3 BD Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Information
11.2.2 Abbott (Include Alere) Molecular Influenza Diagnostic Product Offered
11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott (Include Alere) Main Business Overview
11.2.5 Abbott (Include Alere) Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Molecular Influenza Diagnostic Product Offered
11.3.3 Roche Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Information
11.4.2 SIEMENS Molecular Influenza Diagnostic Product Offered
11.4.3 SIEMENS Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 SIEMENS Main Business Overview
11.4.5 SIEMENS Latest Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Information
11.5.2 Analytik Jena Molecular Influenza Diagnostic Product Offered
11.5.3 Analytik Jena Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Analytik Jena Main Business Overview
11.5.5 Analytik Jena Latest Developments
11.6 Quidel
11.6.1 Quidel Company Information
11.6.2 Quidel Molecular Influenza Diagnostic Product Offered
11.6.3 Quidel Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Quidel Main Business Overview
11.6.5 Quidel Latest Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Information
11.7.2 Thermo Fisher Molecular Influenza Diagnostic Product Offered
11.7.3 Thermo Fisher Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Main Business Overview
11.7.5 Thermo Fisher Latest Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Information
11.8.2 Meridian Bioscience Molecular Influenza Diagnostic Product Offered
11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Meridian Bioscience Main Business Overview
11.8.5 Meridian Bioscience Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Molecular Influenza Diagnostic Product Offered
11.9.3 BioMerieux Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Information
11.10.2 Sekisui Diagnostics Molecular Influenza Diagnostic Product Offered
11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sekisui Diagnostics Main Business Overview
11.10.5 Sekisui Diagnostics Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Molecular Influenza Diagnostic Product Offered
11.11.3 Response Biomedical Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Information
11.12.2 SA Scientific Molecular Influenza Diagnostic Product Offered
11.12.3 SA Scientific Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 SA Scientific Main Business Overview
11.12.5 SA Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Influenza Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Table 3. Major Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests
Table 4. Major Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Table 5. Major Players of Simple Amplification-based Assays (SAMBA)
Table 6. Molecular Influenza Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 9. Molecular Influenza Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 12. Global Molecular Influenza Diagnostic Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Molecular Influenza Diagnostic Revenue Market Share by Player (2019-2024)
Table 14. Molecular Influenza Diagnostic Key Players Head office and Products Offered
Table 15. Molecular Influenza Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Influenza Diagnostic Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Molecular Influenza Diagnostic Market Size Market Share by Regions (2019-2024)
Table 20. Global Molecular Influenza Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Molecular Influenza Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Molecular Influenza Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Molecular Influenza Diagnostic Market Size Market Share by Country (2019-2024)
Table 24. Americas Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 26. Americas Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 28. APAC Molecular Influenza Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Molecular Influenza Diagnostic Market Size Market Share by Region (2019-2024)
Table 30. APAC Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 32. APAC Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 34. Europe Molecular Influenza Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Molecular Influenza Diagnostic Market Size Market Share by Country (2019-2024)
Table 36. Europe Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 38. Europe Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Molecular Influenza Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Molecular Influenza Diagnostic
Table 47. Key Market Challenges & Risks of Molecular Influenza Diagnostic
Table 48. Key Industry Trends of Molecular Influenza Diagnostic
Table 49. Global Molecular Influenza Diagnostic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Molecular Influenza Diagnostic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Molecular Influenza Diagnostic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. BD Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 54. BD Molecular Influenza Diagnostic Product Offered
Table 55. BD Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. BD Main Business
Table 57. BD Latest Developments
Table 58. Abbott (Include Alere) Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 59. Abbott (Include Alere) Molecular Influenza Diagnostic Product Offered
Table 60. Abbott (Include Alere) Main Business
Table 61. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Abbott (Include Alere) Latest Developments
Table 63. Roche Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 64. Roche Molecular Influenza Diagnostic Product Offered
Table 65. Roche Main Business
Table 66. Roche Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Roche Latest Developments
Table 68. SIEMENS Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 69. SIEMENS Molecular Influenza Diagnostic Product Offered
Table 70. SIEMENS Main Business
Table 71. SIEMENS Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. SIEMENS Latest Developments
Table 73. Analytik Jena Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 74. Analytik Jena Molecular Influenza Diagnostic Product Offered
Table 75. Analytik Jena Main Business
Table 76. Analytik Jena Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Analytik Jena Latest Developments
Table 78. Quidel Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 79. Quidel Molecular Influenza Diagnostic Product Offered
Table 80. Quidel Main Business
Table 81. Quidel Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Quidel Latest Developments
Table 83. Thermo Fisher Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 84. Thermo Fisher Molecular Influenza Diagnostic Product Offered
Table 85. Thermo Fisher Main Business
Table 86. Thermo Fisher Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Thermo Fisher Latest Developments
Table 88. Meridian Bioscience Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 89. Meridian Bioscience Molecular Influenza Diagnostic Product Offered
Table 90. Meridian Bioscience Main Business
Table 91. Meridian Bioscience Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Meridian Bioscience Latest Developments
Table 93. BioMerieux Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 94. BioMerieux Molecular Influenza Diagnostic Product Offered
Table 95. BioMerieux Main Business
Table 96. BioMerieux Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. BioMerieux Latest Developments
Table 98. Sekisui Diagnostics Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 99. Sekisui Diagnostics Molecular Influenza Diagnostic Product Offered
Table 100. Sekisui Diagnostics Main Business
Table 101. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Sekisui Diagnostics Latest Developments
Table 103. Response Biomedical Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 104. Response Biomedical Molecular Influenza Diagnostic Product Offered
Table 105. Response Biomedical Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Response Biomedical Main Business
Table 107. Response Biomedical Latest Developments
Table 108. SA Scientific Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 109. SA Scientific Molecular Influenza Diagnostic Product Offered
Table 110. SA Scientific Main Business
Table 111. SA Scientific Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. SA Scientific Latest Developments
Table 1. Molecular Influenza Diagnostic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Table 3. Major Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests
Table 4. Major Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Table 5. Major Players of Simple Amplification-based Assays (SAMBA)
Table 6. Molecular Influenza Diagnostic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 9. Molecular Influenza Diagnostic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 12. Global Molecular Influenza Diagnostic Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Molecular Influenza Diagnostic Revenue Market Share by Player (2019-2024)
Table 14. Molecular Influenza Diagnostic Key Players Head office and Products Offered
Table 15. Molecular Influenza Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Influenza Diagnostic Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Molecular Influenza Diagnostic Market Size Market Share by Regions (2019-2024)
Table 20. Global Molecular Influenza Diagnostic Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Molecular Influenza Diagnostic Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Molecular Influenza Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Molecular Influenza Diagnostic Market Size Market Share by Country (2019-2024)
Table 24. Americas Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 26. Americas Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 28. APAC Molecular Influenza Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Molecular Influenza Diagnostic Market Size Market Share by Region (2019-2024)
Table 30. APAC Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 32. APAC Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 34. Europe Molecular Influenza Diagnostic Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Molecular Influenza Diagnostic Market Size Market Share by Country (2019-2024)
Table 36. Europe Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 38. Europe Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Molecular Influenza Diagnostic Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Molecular Influenza Diagnostic
Table 47. Key Market Challenges & Risks of Molecular Influenza Diagnostic
Table 48. Key Industry Trends of Molecular Influenza Diagnostic
Table 49. Global Molecular Influenza Diagnostic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Molecular Influenza Diagnostic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Molecular Influenza Diagnostic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. BD Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 54. BD Molecular Influenza Diagnostic Product Offered
Table 55. BD Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. BD Main Business
Table 57. BD Latest Developments
Table 58. Abbott (Include Alere) Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 59. Abbott (Include Alere) Molecular Influenza Diagnostic Product Offered
Table 60. Abbott (Include Alere) Main Business
Table 61. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Abbott (Include Alere) Latest Developments
Table 63. Roche Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 64. Roche Molecular Influenza Diagnostic Product Offered
Table 65. Roche Main Business
Table 66. Roche Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Roche Latest Developments
Table 68. SIEMENS Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 69. SIEMENS Molecular Influenza Diagnostic Product Offered
Table 70. SIEMENS Main Business
Table 71. SIEMENS Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. SIEMENS Latest Developments
Table 73. Analytik Jena Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 74. Analytik Jena Molecular Influenza Diagnostic Product Offered
Table 75. Analytik Jena Main Business
Table 76. Analytik Jena Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Analytik Jena Latest Developments
Table 78. Quidel Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 79. Quidel Molecular Influenza Diagnostic Product Offered
Table 80. Quidel Main Business
Table 81. Quidel Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Quidel Latest Developments
Table 83. Thermo Fisher Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 84. Thermo Fisher Molecular Influenza Diagnostic Product Offered
Table 85. Thermo Fisher Main Business
Table 86. Thermo Fisher Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Thermo Fisher Latest Developments
Table 88. Meridian Bioscience Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 89. Meridian Bioscience Molecular Influenza Diagnostic Product Offered
Table 90. Meridian Bioscience Main Business
Table 91. Meridian Bioscience Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Meridian Bioscience Latest Developments
Table 93. BioMerieux Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 94. BioMerieux Molecular Influenza Diagnostic Product Offered
Table 95. BioMerieux Main Business
Table 96. BioMerieux Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. BioMerieux Latest Developments
Table 98. Sekisui Diagnostics Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 99. Sekisui Diagnostics Molecular Influenza Diagnostic Product Offered
Table 100. Sekisui Diagnostics Main Business
Table 101. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Sekisui Diagnostics Latest Developments
Table 103. Response Biomedical Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 104. Response Biomedical Molecular Influenza Diagnostic Product Offered
Table 105. Response Biomedical Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Response Biomedical Main Business
Table 107. Response Biomedical Latest Developments
Table 108. SA Scientific Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 109. SA Scientific Molecular Influenza Diagnostic Product Offered
Table 110. SA Scientific Main Business
Table 111. SA Scientific Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. SA Scientific Latest Developments
LIST OF FIGURES
Figure 1. Molecular Influenza Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Influenza Diagnostic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Molecular Influenza Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Molecular Influenza Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Molecular Influenza Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Molecular Influenza Diagnostic Market Size Market Share by Type in 2023
Figure 10. Molecular Influenza Diagnostic in Hospitals
Figure 11. Global Molecular Influenza Diagnostic Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Molecular Influenza Diagnostic in POCT
Figure 13. Global Molecular Influenza Diagnostic Market: POCT (2019-2024) & ($ Millions)
Figure 14. Molecular Influenza Diagnostic in Others
Figure 15. Global Molecular Influenza Diagnostic Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Molecular Influenza Diagnostic Market Size Market Share by Application in 2023
Figure 17. Global Molecular Influenza Diagnostic Revenue Market Share by Player in 2023
Figure 18. Global Molecular Influenza Diagnostic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Molecular Influenza Diagnostic Value Market Share by Country in 2023
Figure 24. United States Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Molecular Influenza Diagnostic Market Size Market Share by Region in 2023
Figure 29. APAC Molecular Influenza Diagnostic Market Size Market Share by Type in 2023
Figure 30. APAC Molecular Influenza Diagnostic Market Size Market Share by Application in 2023
Figure 31. China Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Molecular Influenza Diagnostic Market Size Market Share by Country in 2023
Figure 38. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 57. United States Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 61. China Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 65. India Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 68. France Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 69. UK Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 78. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Molecular Influenza Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Influenza Diagnostic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Molecular Influenza Diagnostic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Molecular Influenza Diagnostic Sales Market Share by Country/Region (2023)
Figure 8. Molecular Influenza Diagnostic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Molecular Influenza Diagnostic Market Size Market Share by Type in 2023
Figure 10. Molecular Influenza Diagnostic in Hospitals
Figure 11. Global Molecular Influenza Diagnostic Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Molecular Influenza Diagnostic in POCT
Figure 13. Global Molecular Influenza Diagnostic Market: POCT (2019-2024) & ($ Millions)
Figure 14. Molecular Influenza Diagnostic in Others
Figure 15. Global Molecular Influenza Diagnostic Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Molecular Influenza Diagnostic Market Size Market Share by Application in 2023
Figure 17. Global Molecular Influenza Diagnostic Revenue Market Share by Player in 2023
Figure 18. Global Molecular Influenza Diagnostic Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 20. APAC Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 21. Europe Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Molecular Influenza Diagnostic Market Size 2019-2024 ($ Millions)
Figure 23. Americas Molecular Influenza Diagnostic Value Market Share by Country in 2023
Figure 24. United States Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Molecular Influenza Diagnostic Market Size Market Share by Region in 2023
Figure 29. APAC Molecular Influenza Diagnostic Market Size Market Share by Type in 2023
Figure 30. APAC Molecular Influenza Diagnostic Market Size Market Share by Application in 2023
Figure 31. China Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Molecular Influenza Diagnostic Market Size Market Share by Country in 2023
Figure 38. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Figure 39. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Figure 40. Germany Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Molecular Influenza Diagnostic Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 54. APAC Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 55. Europe Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 57. United States Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 58. Canada Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 61. China Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 62. Japan Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 63. Korea Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 65. India Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 66. Australia Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 67. Germany Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 68. France Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 69. UK Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 70. Italy Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 71. Russia Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 72. Spain Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 75. Israel Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Molecular Influenza Diagnostic Market Size 2025-2030 ($ Millions)
Figure 78. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Application (2025-2030)
